Colossal Biosciences’ $200 Million Series C Financing Round

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Colossal Biosciences in the transaction.Colossal Biosciences, the world’s first de-extinction company, announced it raised $200 million in Series…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here